These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18524195)

  • 41. Balloon dilatation for treatment of congenital nasolacrimal duct obstruction.
    Yüksel D; Ceylan K; Erden O; Kiliç R; Duman S
    Eur J Ophthalmol; 2005; 15(2):179-85. PubMed ID: 15812757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success.
    Kashkouli MB; Kassaee A; Tabatabaee Z
    J AAPOS; 2002 Dec; 6(6):360-3. PubMed ID: 12506276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topical mitomycin in endoscopic-assisted probing for the treatment of congenital nasolacrimal duct obstruction in older children.
    Galindo-Ferreiro A; Khandekar R; Akaishi PM; Cruz AAV; Galvez-Ruiz A; Dolmetsch A; Schellini SA
    Arq Bras Oftalmol; 2020 Jun; 83(3):229-235. PubMed ID: 32490970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Congenital nasolacrimal duct obstruction: irrigation or probing?
    Kim YS; Moon SC; Yoo KW
    Korean J Ophthalmol; 2000 Dec; 14(2):90-6. PubMed ID: 11213741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stepwise treatment paradigm for congenital nasolacrimal duct obstruction.
    Casady DR; Meyer DR; Simon JW; Stasior GO; Zobal-Ratner JL
    Ophthalmic Plast Reconstr Surg; 2006; 22(4):243-7. PubMed ID: 16855492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unlocking the secrets of success in probing for congenital nasolacrimal duct obstruction: investigating the factors that matter.
    Kocabas S; Oklar M; Ozturk Y; Rodop Ozgur O
    Int Ophthalmol; 2024 May; 44(1):221. PubMed ID: 38717720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of nasolacrimal duct obstruction with probing in children younger than 4 years].
    Mrugacz M; Sielicka D; Bakunowicz-Łazarczyk A
    Klin Oczna; 2010; 112(7-9):221-2. PubMed ID: 21121125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inferior turbinate fracture and congenital nasolacrimal duct obstruction.
    Attarzadeh A; Sajjadi M; Owji N; Reza Talebnejad M; Farvardin M; Attarzadeh A
    Eur J Ophthalmol; 2006; 16(4):520-4. PubMed ID: 16952088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Success rates of dacryoendoscopy-guided probing for recalcitrant congenital nasolacrimal duct obstruction.
    Fujimoto M; Ogino K; Matsuyama H; Miyazaki C
    Jpn J Ophthalmol; 2016 Jul; 60(4):274-9. PubMed ID: 27116947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of the Masterka for complex nasolacrimal duct obstruction in children.
    Khatib L; Nazemzadeh M; Revere K; Katowitz WR; Katowitz JA
    J AAPOS; 2017 Oct; 21(5):380-383. PubMed ID: 28917994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Success Rates of Conventional Versus Endoscope-Assisted Probing for Congenital Nasolacrimal Duct Obstruction in Children 12 Years and Younger.
    Galindo-Ferreiro A; Akaishi P; Cruz A; Khandekar R; Dossari S; Dufaileej M; Galvez-Ruiz A; Schellini S
    J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):292-9. PubMed ID: 27383144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prevalence of amblyogenic factors in children with persistent congenital nasolacrimal duct obstruction.
    Eshraghi B; Akbari MR; Fard MA; Shahsanaei A; Assari R; Mirmohammadsadeghi A
    Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1847-52. PubMed ID: 24777709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction.
    Cha DS; Lee H; Park MS; Lee JM; Baek SH
    Korean J Ophthalmol; 2010 Oct; 24(5):261-6. PubMed ID: 21052504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of treatment modalities and prognostic factors in children with congenital nasolacrimal duct obstruction.
    Al-Faky YH; Al-Sobaie N; Mousa A; Al-Odan H; Al-Huthail R; Osman E; Al-Mosallam AR
    J AAPOS; 2012 Feb; 16(1):53-7. PubMed ID: 22370666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Management of congenital nasolacrimal duct obstruction].
    Castelo Branco Neto E; Castelo Branco B; Cardoso CC; Carvalho RG; Mota E; Castelo Branco A
    Arq Bras Oftalmol; 2009; 72(1):75-8. PubMed ID: 19347127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endoscopic-assisted probing for congenital nasolacrimal duct obstruction.
    Wallace EJ; Cox A; White P; Macewen CJ
    Eye (Lond); 2006 Sep; 20(9):998-1003. PubMed ID: 16138115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endoscopic-assisted retrieval of retained lacrimal stent material in congenital nasolacrimal duct obstruction without dacryocystorhinostomy.
    Ng DS; Chan E; Tong FM; Chow SK; Ko ST
    Orbit; 2016; 35(2):103-5. PubMed ID: 26838355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simple technique for silicone intubation in congenital nasolacrimal duct obstruction.
    Lekskul A; Khamapirad B; Nimvorapun T
    J Med Assoc Thai; 2004 Sep; 87(9):1082-6. PubMed ID: 15516010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Probing for congenital nasolacrimal duct obstruction: a systematic review and meta-analysis of randomized clinical trials.
    Farat JG; Schellini SA; Dib RE; Santos FGD; Meneghim RLFS; Jorge EC
    Arq Bras Oftalmol; 2021; 84(1):91-98. PubMed ID: 33470349
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of metal-metal contact during nasolacrimal duct probing.
    Mocan MC; Gulmez Sevim D; Kocabeyoglu S; Irkec M
    Can J Ophthalmol; 2015 Aug; 50(4):314-7. PubMed ID: 26257227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.